4D Pharma PLC - Leeds, England-based pharmaceutical company - Files shelf registration statement to the US Securities & Exchange Commission following which the company may offer up to USD150.0 million of shares in the form of American Depositary Shares, with each ADS reflecting eight ordinary shares.
The specifics of the offering has not been disclosed, however proceeds from the offering will go towards general corporate purposes.
Current stock price: 27.90 pence, up 6.5%
12-month change: down 77%
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
